ÂÜÀòÂÒÂ×

Crawford Parker has extensive experience in clinical safety and pharmacovigilance, having served in various leadership roles since beginning a career at Pfizer as Associate Director of Experimental Medicine from June 2000 to March 2002. Crawford continued to advance professionally at Roche as Director of Drug Safety from March 2002 to June 2005, followed by a tenure at AbbVie as Group Head of Clinical Safety from June 2005 to November 2010. Currently, Crawford holds the position of Executive Director at Daiichi Sankyo, Inc., having previously served as Senior Director, focusing on clinical safety within both pre and postmarketing environments. Educational qualifications include a Doctor of Medicine (MD) from Joan & Sanford I. Weill Medical College of Cornell University, a Bachelor of Arts in Biology from Case Western Reserve University, and a fellowship in Clinical Pharmacology from Georgetown University.